The PQI Podcast

In the Season 10 finale of the PQI Podcast, host Ginger Blackmon is joined by NCODA Fellow Shawnny Eugene, PharmD, as co-host for a special conversation focused on pharmacy fellowships and professional development. Together, they welcome three former fellows who have taken unique career paths following their fellowship experiences: Cooper Bailey, PharmD, Rahil Dixit, PharmD, and Utoy Wong, PharmD....

Season 10, Episode 14: Optimizing Access Through OOLD In this episode of the PQI Podcast, we explore Oncology Optimized Limited Distribution (OOLD) and its growing importance within patient-centered oncology care. Guests Jonas Congelli, RPh, and Ken Komorny, PharmD, BCPS, discuss how distribution models impact oncology practices, care coordination, and the patient experience, while highlighting th...

In this episode of the PQI Podcast, we are joined by Chadi Nabhan, MD, MBA, FACP, nationally recognized oncology leader, physician-executive, author, and host of the Healthcare Unfiltered podcast. Dr. Nabhan discusses his career journey across academic medicine, clinical oncology, healthcare leadership, precision medicine, and artificial intelligence innovation. The conversation explores how AI is...

In this episode of the PQI Podcast, we sit down with Brian I. Rini, MD, FASCO, Ingram Professor of Medicine at Vanderbilt University Medical Center and Vanderbilt-Ingram Cancer Center, and co-host of the popular GU oncology podcast Uromigos, for a conversation on the evolution of genitourinary oncology and GU cancer care. Dr. Rini shares how mentorship and early exposure to GU oncology helped shap...

Season 10, Episode 11: Your Best Meeting Ever with Rebecca Hinds, PhD In this episode, we welcome Rebecca Hinds, PhD, to discuss her new book, Your Best Meeting Ever , and how teams can rethink the role of meetings in today’s evolving workplace. Drawing on her background in organizational behavior and research at Asana and Glean, Rebecca shares how meetings can be treated as products—designed with...

Season 10, Episode 10: Clearing the Fog: A Clinical Look at Chemo Brain with Jorg Dietrich, MD, PhD Cognitive changes during cancer treatment, often called “chemo brain,” can significantly impact a patient’s quality of life. In this episode, Jorg Dietrich, MD, PhD, Clinical Director of the Cancer & Neurotoxicity Clinic at Massachusetts General Hospital and Associate Professor of Neurology at Harva...

In this episode of The PQI Podcast, John Burke, MD (Rocky Mountain Cancer Centers), shares his perspective on bringing clinical trials into the community oncology setting—where most patients are treated, but research isn’t always built in. He walks through why expanding research beyond academic centers matters, especially when it comes to improving access, increasing diversity in trial participati...

Artificial intelligence is rapidly shaping the future of oncology, but for many clinicians, the question remains: how can it be applied in a meaningful and practical way? In this episode, we are joined by Sanjay Juneja, MD,  Vice President of AI and Medical Informatics at Tempus AI and a practicing hematologist and medical oncologist, to explore the evolving role of AI in oncology care. Known to m...

Season 10, Episode 7: Scaling Hope: The Future of Cell Therapy Access   In this episode of the PQI Podcast, Fabian Gerlinghaus, Co-founder and CEO of Cellares, shares insights into the evolving landscape of cell therapy manufacturing and its impact on patient access. Fabian discusses his background as an aerospace engineer turned biotech innovator and the inspiration behind founding Cellares, a co...

In this episode, we welcome Kirollos Hanna, PharmD, BCPS, BCOP, a recognized leader in oncology pharmacy practice and research. Dr. Hanna shares insights into the evolving landscape of antibody-drug conjugates (ADCs) and the unique challenges they present in managing chemotherapy-induced nausea and vomiting (CINV).  As ADC use expands, oncology teams are observing new and sometimes underrecognized...

PQI Podcast | Season 10, Episode 5 Subcutaneous Anticancer Biologics: Best Practices for Safe Administration 0.5 hours of CE for Pharmacists, Pharmacy Technicians, and Nurses Guests: Tonya Bauer, MSN, RN, OCN Karlee De Voss, MSN, RN Sylvia Sabala, RN, OCN As oncology care continues to evolve, subcutaneous administration of anticancer therapies is becoming an increasingly important strategy to impr...

PQI Podcast | Season 10, Episode 4 Blood Clots and Cancer: What Every Oncology Team Should Know March is Blood Clot Awareness Month, making it the perfect time to spotlight an often overlooked but life-threatening complication in cancer care: blood clots. In this episode of the PQI Podcast, we speak with Leslie Lake, Voluntary President and Board Chair of the National Blood Clot Alliance (NBCA). A...

In Season 10, Episode 3 of the PQI Podcast, we are joined by Laura Bray, MBA, founder and Chief Change Maker of Angels for Change, to explore one of the most urgent challenges in oncology today: drug shortages. Laura shares the powerful personal story that led to the creation of Angels for Change after her daughter faced multiple life-saving drug shortages during cancer treatment. She provides a p...

Bhavana (Tina) Bhatnagar, DO—Associate Professor of Medicine at the WVU Cancer Institute—shares her journey from academic centers to rural West Virginia, where she’s working to expand access and improve outcomes for underserved communities. We talk about what high-quality rural cancer care really takes: overcoming transportation and financial barriers, navigating limited specialty resources, build...

Season 10, Episode 1 of the PQI Podcast kicks off with a global perspective on cancer care, featuring Eoin Tabb, a leading oncology and haematology pharmacist in Ireland. Eoin serves as Chief 2 Pharmacist for Clinical Cancer Services at University Hospital Waterford, hosts the Irish Haematology Oncology Podcast, and is the Chairperson of the Irish Pharmacy Haematology Oncology Society. In this epi...

Bill Wimbiscus is a longtime journalist and NCODA collaborator—and in this bonus episode, he shares what it felt like to go from reporter to patient after a multiple myeloma diagnosis. He talks candidly about the realities that show up outside the clinic: oral oncolytic logistics, specialty deliveries, dose changes, and the financial uncertainty that can derail care. Bill’s connection to NCODA sta...

Nuclear pharmacy is rapidly moving from the background to the forefront of oncology care. In this season finale episode, Nic Mastiscusa, PharmD, Chief Nuclear Pharmacist at the University of Iowa Hospitals and Clinics, breaks down how theranostics and radiopharmaceutical therapies are changing the way certain cancers are diagnosed and treated. Nick explains how targeted radioactive drugs can both...

Melanoma used to have almost no effective treatment options. Now? Immunotherapy is changing lives — and Oxford’s Dr. Mark Middleton joins us to unpack the science, the turning points, and the innovations reshaping melanoma care. In this episode, he reflects on decades of research — from the early trials that taught researchers what not to do, to the breakthroughs in checkpoint inhibition and preci...

In this special Giving Tuesday episode, Ginger talks with Chuck Akanegbu, PharmD, a PGY1 resident and longtime NCODA PSO leader, whose involvement in the student community led to something bigger than he ever expected: donating stem cells through the National Marrow Donor Program (NMDP). Chuck reflects on how the PSO shaped his interest in oncology, what leadership taught him, and how he went from...

What happens when a group of breast cancer survivors climb into a 40-foot boat and start paddling together? You get the Mammoglams — a Jacksonville dragon boat team turning survivorship into strength, resilience, and community! In this episode, we’re joined by Pam Reckner , breast cancer survivor, Team USA paddler, and Team Captain of the Mammoglams, along with Jeri Millard , breast cancer survivo...

This Veterans Day, we’re shining a light on care for those who’ve served. Dr. Elizabeth (Betsy) O’Donnell , Director of the Multi-Cancer Early Detection Clinic at Dana-Farber Cancer Institute , joins the PQI Podcast to discuss the Sentinel Study —a Department of Defense–sponsored clinical trial offering multi-cancer early detection (MCED) testing to U.S. veterans. Through a single blood draw, the...

Before every breakthrough in oncology, there’s phase I research — where innovation, teamwork, and patient trust come together. In this episode, Dr. R. Donald Harvey, PharmD, BCOP, FCCP, FHOPA, FASCO, Vice President of Clinical Research and Executive Director of the Emory Clinical Research Office, joins hosts Ginger Blackmon, PharmD, and Maddy Floysand, PharmD, for an inside look at how early-phase...

In cancer care, ethical challenges rarely come with easy answers. When should treatment stop? How do teams manage moral distress? And what happens when AI begins to shape clinical decisions? In this episode, Dr. Nico Nortjé, Executive Director for the Center for Clinical Ethics in Cancer Care at MD Anderson Cancer Center, joins host Ginger to explore how oncology professionals navigate those momen...

We talk a lot about caring for patients — but what about caring for ourselves? This week, Ginger sits down with Amy Morin, LCSW, for an honest conversation about what mental strength really looks like in oncology practice. From navigating grief and burnout to finding balance between empathy and endurance, Amy shares real strategies to stay steady when the work feels heavy. A psychotherapist and be...

When Dr. Rupa Gupta set out to open Lotus Oncology & Hematology , she wanted more than a clinic — she wanted a sanctuary.  In this episode of the PQI Podcast, Dr. Gupta shares how she built a practice that blends evidence-based treatment with compassion, mindfulness, and community connection. She discusses designing a healing environment filled with light and art, integrating therapies like acupun...